Safety Planning + Give to Others Module for Suicidal Thoughts
Trial Summary
What is the purpose of this trial?
This project is designed to test a brief therapy to reduce suicidal ideation among a diverse sample of youths ages 12 to 17 who experience anxiety or depression. The goal of the study is to conduct a clinical trial testing whether this therapy reduces suicidal ideation and related beliefs that one is a burden on others. This project will contribute to the field by potentially showing evidence supportive of a brief strategy to reduce suicidal ideation in a way that can be readily understood and used by mental health providers in the community.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are currently involved in a psychosocial treatment, you may be excluded from participating.
What data supports the effectiveness of the treatment Give to Others Module for suicidal thoughts?
Research on safety planning interventions, which are similar to the Give to Others Module, shows they can effectively reduce suicidal behavior by helping individuals identify coping strategies and engage supportive relationships. These interventions have been found to decrease suicidal ideation and behavior, as well as reduce depression and hopelessness.12345
Is the Safety Planning + Give to Others Module safe for humans?
How does the Give to Others Module treatment for suicidal thoughts differ from other treatments?
The Give to Others Module is unique because it combines safety planning with a focus on enhancing social connections and altruistic behavior, which is not a standard approach in existing treatments for suicidal thoughts. This treatment emphasizes the importance of social relationships and giving to others as a way to cope with suicidal urges, which is a novel aspect compared to traditional interventions.23468
Research Team
Victor Buitron, PhD
Principal Investigator
Florida International University
Eligibility Criteria
This trial is for youths aged 12 to 17 who are experiencing anxiety or depression, have thoughts of being a burden on others, and show signs of suicidal ideation. It's not specified who can't join the trial.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a brief therapy module to reduce suicidal ideation, including the 'Give to Others' module or a safety planning protocol
Follow-up
Participants are monitored for changes in perceived burdensomeness and suicidal ideation post-treatment
Treatment Details
Interventions
- Give to Others Module
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida International University
Lead Sponsor